The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 7537-7549
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khuda, S. E.
Right arrow Articles by Erickson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khuda, S. E.
Right arrow Articles by Erickson, L. D.

Deregulation of c-Myc Confers Distinct Survival Requirements for Memory B Cells, Plasma Cells, and Their Progenitors1

Sefat E. Khuda*, William M. Loo*, Siegfried Janz{dagger}, Brian Van Ness{ddagger} and Loren D. Erickson2,*

* Department of Microbiology, University of Virginia, Charlottesville, VA 22908; {dagger} Department of Pathology, University of Iowa, Iowa City, IA 52242; and {ddagger} Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis MN 55455

Deregulation of the c-Myc oncogene is tightly associated with human and murine plasma cell (PC) neoplasms. Through the analysis of Ag-specific B cell responses in mice where Myc is targeted to the Igh C{alpha} locus, we show here that c-Myc dramatically impairs the primary and secondary Ab response. This impairment is differentiation stage specific, since germinal center B cell formation, affinity maturation, and class switch recombination were intact. Examination of PC viability revealed that c-Myc triggered apoptosis only upon final maturation when Ab is secreted and is resistant to the survival factor BAFF (B cell-activating factor belonging to the TNF family). In contrast, PC precursors (PCpre) that ultimately give rise to mature PCs survived normally and vigorously expanded with BAFF signaling. We further show that c-Myc also facilitates the apoptosis of memory B cells. Thus, C{alpha}-Myc controls both cellular arms of long-lived B cell immunity than previously anticipated. Only when deregulation of c-Myc was combined with enforced Bcl-xL expression were mature PCs able to survive in response to BAFF. These data indicate that the survival requirements for tumor-susceptible PCpre and PCs are distinct and that tumor progression likely develops as PCpre transition to functional PCs when apoptotic pathways such as members of the Bcl-2 family are disabled.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the American Cancer Society and the Leukemia Research Foundation (to L.D.E.) and by the University of Virginia Cancer Center for Core support.

2 Address correspondence and reprint requests to Dr. Loren D. Erickson, Department of Microbiology, University of Virginia, Jordan Hall, Room 7034, 1300 Jefferson Park Avenue, Charlottesville, VA 22908. E-mail address: lde9w{at}virginia.edu

3 Abbreviations used in this paper: PC, plasma cell; TI, T cell independent; TD, T cell dependent; GC, germinal center; BM, bone marrow; MM, multiple myeloma; BAFF, B cell-activating factor belonging to the TNF family; BL, Burkitt’s lymphoma; BCMA, B cell maturation Ag; PCpre, PC precursor; NP, (4-hydroxy-3-nitrophenyl)acetyl; KLH, keyhole limpet hemocyanin; ZVAD, benzylocarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone; DAPI, 4',6-diamidino-2-phenylindole; 7-AAD, 7-aminoactinomycin D; CT, cycle threshold; FO, follicular; CDK, cyclin-dependent kinase; MZ, marginal zone; AID, activation-induced cytidine deaminase; Bmem, B memory cell; TACI, transmembrane activator and calcium-modulator and cytophilin ligand interactor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.